港股異動 | 康德萊醫械漲逾12% 績後已累漲逾24%
格隆匯3月24日丨康德萊醫械(1501.HK)上週四(19日)晚間公佈2019年度業績稱,期內實現收入2.86億元(人民幣,下同),同比增長41.07%;毛利1.74億元,同比增長47.34%;年度純利9961.4萬元,同比增長70.42%;基本及攤薄0.79元,擬派末期息每股0.175元。期內,介入類醫療器械銷量的顯著增長,得益於公司積極開拓分銷網絡,持續地研發並商業化研發管線的產品並推向醫院和醫療器械製造商客户。與2018年相較,毛利率由58.31%增加至60.90%,主要原因是集團產品結構優化,將更多資源分配至製造及銷售具有更高利潤率的介入類產品。業績公佈後至今,康德萊醫械已累漲逾24%,現報37港元,漲12.12%,暫成交230萬港元,最新總市值61億港元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.